
Core Research AreasPharmaceutical Intermediates
The team focuses on the development and process optimization of high
value-added pharmaceutical intermediates. They specialize in complex organic
synthesis reactions such as Grignard reactions, cryogenic reactions, and
diazotization reactions, and are committed to delivering high-purity,
cost-effective, and environmentally friendly customized solutions for
pharmaceutical companies.OLED Luminescent Material Intermediates
Keeping pace with the cutting-edge advancements in optoelectronic materials,
the team is dedicated to the molecular design and synthetic process development
of high-performance OLED intermediates. Their work supports the industrial
application of next-generation display materials and drives technological
upgrading in domestic high-end electronic materials.Technical Advantages
- Expertise in Specialized Reactions: The team has strong capabilities in key technologies such as Grignard reactions, cryogenic reactions, and diazotization. They can precisely control reaction conditions and optimize
process routes to achieve efficient and stable industrial-scale production. - End-to-End R&D Capability: From molecular design and laboratory optimization to pilot-scale production, the team possesses a comprehensive R&D transformation capability, ensuring rapid implementation of technological achievements.
- Interdisciplinary Collaboration: Through the integration of talents from multiple fields, the team continuously breaks through industry bottlenecks and improves innovation efficiency.
- Expertise in Specialized Reactions: The team has strong capabilities in key technologies such as Grignard reactions, cryogenic reactions, and diazotization. They can precisely control reaction conditions and optimize